Novel Drug-Coated Balloon Saw Lower In-Lesion LLL vs. Drug-Eluting Stent in PICCOLETO II Trial
The novel Elutax SV drug-coated balloon (DCB) resulted in significantly lower in-lesion late lumen loss (LLL) for small-vessel coronary artery disease (SVD) patients than the Xience everolimus-eluting stent in the European PICCOLETO II trial.